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Background: Multifunctional L-amino acid oxidases (LAAOs) occur widely in snake venoms.
Methods: The L-AAO from Bothrops leucurus (Bl-LAAO) venom was puriﬁed using a combination of molecular
exclusion and ion-exchange chromatographies. We report some biochemical features of Bl-LAAO associated
with its effect on platelet function and its cytotoxicity.
Results: Bl-LAAO is a 60 kDa monomeric glycoprotein. Its N-terminal sequence shows high homology to other
members of the snake-venom LAAO family. Bl-LAAO catalyzes oxidative deamination of L-amino acids with
the generation of H2O2. The best substrates were: L-Met, L-Norleu, L-Leu, L-Phe and L-Trp. The effects of snake
venom LAAOs in hemostasis, especially their action on platelet function remain largely unknown. Bl-LAAO
dose-dependently inhibited platelet aggregation of both human PRP and washed platelets. Moreover, the
puriﬁed enzyme exhibited a killing effect in vitro against Leishmania sp., promastigotes, with a very low EC50
of 0.07 μM. Furthermore, the cytotoxicity of Bl-LAAO was observed in the stomach cancer MKN-45, adeno
carcinoma HUTU, colorectal RKO and human ﬁbroblast LL-24 cell lines. The enzyme released enough H2O2 in
culture medium to induce apoptosis in cells in a dose- and time-dependent manner. The biological effects
were inhibited by catalase.
Conclusion: Bl-LAAO, a major component of B. leucurus venom, is a cytotoxin acting primarily via the
generation of high amounts of H2O2 which kill the cells.
General signiﬁcance: These results allow us to consider the use of LAAOs as anticancer agents, as tools in
biochemical studies to investigate cellular processes, and to obtain a better understanding of the
envenomation mechanism.
© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
L-amino acid oxidases (LAAOs) are ﬂavoproteins which are able to
catalyze the oxidative deamination of L-amino acids to produce the
corresponding α-keto acids along with the concomitant release of
hydrogen peroxide (H202) and ammonia. Although they occur in
many different organisms from invertebrates to vertebrates, their
functions in vivo are uncertain. LAAO (EC 1.4.3.2) is widely distributed
in venomous snakes including the viperids and elapids and is thought, 5-diphenyltetra-zolium]; IC50,
D, o-phenylenediamine; DMC,
Bothrops leucurus venom; i.p,
id; 2-DE, two-dimensional gel
: +55 31 33711753.
hez).
sevier OA license.to contribute to their toxicity, possibly through H202 formed as a
result of reoxidation of the transiently reduced FAD cofactor by
molecular oxygen [1]. The enzyme is the major component of snake
venoms, and in some venom species this enzyme alone constitutes
approximately 30% of the total protein content [2,3]. It has been
reported to exert a multiplicity of effects on biological organisms
including the induction or inhibition of platelet aggregation [4–6].
These enzymes also exhibit antibacterial and antiviral properties,
abolishing the growth of both Gram-positive and -negative pro-
karyotes as well as HIV [7–9]. Furthermore, venom LAAO has been
shown to induce cell death in several mammalian cell lines [10,11].
The effect was attributed to the formation of localized high
concentrations of H202, a known reactive oxygen specie (ROS). It is
interesting to note that the LAAO-induced apoptosis has been
reported to be different from that caused by exogenous H202,
suggesting that the mode of delivery of H202 is an important factor
[12]. In addition, snake venom LAAOs appear to be cytotoxic against
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individual LAAOs differ in their structure, substrate speciﬁcity as well
as in their biological properties. Thus, ophidian LAAO has become an
attractive target for research in molecular biochemistry, physiology
and medicine due to its multiple effects on several cells.
The pit viper Bothrops leucurus (White-tailed-jararaca) is a
poisonous snake habitating areas in the northeast of Brazil. In those
regions B. leucurus is the leading cause of human accidents and
constitutes a relevant public health issue. The venom exerts
diversiﬁed local and hematological effects and the bites are followed
by hemostatic failure. The LD50 by ventricular, intraperitoneal and
intravenous routes were 5.7, 85.6 and 18.3 μg, respectively, per 20 g
mouse [14]. The venom contains hemorrhagic and anticoagulant
activities associated with active toxins such as P-I and P-III
metalloproteinases [15–17] and procoagulant activity related to
thrombin-like enzyme [18]. Phospholipases A2 reported as K49 and
D49 [19] have been isolated from this venom and are under
investigation. In addition, the venom has effects on a wide variety of
physiological and pathological processes, including inﬂammation,
edema, hemolysis and cancermetastasis. However, compared to other
Brazilian Bothrops snakes, the toxinology of B. leucurus venom is still
poorly studied, and so far, no component from this venom with LAAO
activity has been reported. In view of the lack of information, we have
puriﬁed an LAAO from B. leucurus venom named Bl-LAAO and have
studied some of its biochemical and pharmacological properties. Our
results have important implications for understanding the envenom-
ation by B. leucurus as well as the mechanisms of cell death triggered
by this group of enzymes and provide a foundation for further
investigations.
2. Materials and methods
2.1. Materials
Venom of B. leucurus was from the Ezequiel Dias Foundation
Serpentarium, Belo Horizonte, Brazil. Horseradish peroxidase, cata-
lase, o-phenylenediamine, L-leucine and hydrogen peroxide were
from Sigma (St. Louis, USA). Collagen and ADP were from Helena
Laboratories, USA. N-glycosidase F (PNGase F) was from New England
Biolabs, USA and o-glycosidase from BoehringerMannheim, Germany.
Live/Dead viability/cytotoxicity kit for mammalian cells (Molecular
Probes, Inc. USA); Other chemicals were of analytical grade. The
experiments reported here were conducted according to the
guidelines established by the Brazilian College for Animal Experi-
mentation and approved by the local Ethics Committee.
2.2. Puriﬁcation of Bl-LAAO
Lyophilized B. leucurus venom (2 g) was dissolved in 12 ml of
50 mM ammonium acetate buffer (pH 7.4) containing 0.3 M NaCl and
centrifuged at 6000×g (10 min at 4 °C) to remove the insoluble
material. In the ﬁrst step, the solution (1850 mg protein in 12 ml) was
applied to two 2.5×100 cm columns in series packed with Sephacryl
S-200, equilibrated and elutedwith the same buffer. The ﬂow rate was
7 ml/h and 7 ml fractions were collected at 4 °C. The fractions were
monitored by spectrophotometry at 280 nm and tested for LAAO
activity. For the second step, fractions with LAAO activity were
concentrated in aMicrocon concentrator (Millipore) to 4 ml (275 mg)
and applied to a Sephacryl S-300 (1.5×100 cm) column equilibrated
and eluted with 25 mM Tris–HCl buffer (pH 8.0) containing 10 mM
NaCl. Active fractions were pooled, dialyzed against distilled water
and lyophilized. This material (83 mg) containing protein impurities
was applied to a DEAE Sepharose CL 6B (1.0×19 cm) column,
equilibrated with 25 mM Hepes buffer, pH 7.5. The bound proteins
were eluted with a 0–0.3 M NaCl gradient in the same buffer at a ﬂow
rate of 14 ml/h.2.3. Protein characterization
For purity analysis, 200 μg of the BL-LAAO obtained from the DEAE
Sepharose column was applied onto a RP HPLC C4 (4.6×250 mm)
column, equilibrated with 0.1% aqueous TFA, which was eluted with a
gradient of ACN (0–60%) in 0.1% TFA. The molecular mass (Mr)
of puriﬁed BL-LAAO was determined by gel ﬁltration using a Sephacryl
S-200 (1.0×37 cm) columnelutedwith20 mMTris–HCl buffer (pH7.5)
containing 0.15 M NaCl at a ﬂow rate of 6 ml/h. The Mr markers
were BSA, (66 kDa), ovalbumin (45 kDa), trypsinogen (25 kDa) and
α-lactalbumin (14.4 kDa). The Mr was also determined by polyacryl-
amide gel electrophoresis (12%) according to [20] and by MALDI TOF
mass spectrometry. The N-terminal amino acid sequence was deter-
mined by automated Edman degradation using a Shimadzu PPSQ-21
protein sequencer according to the manufacturer's instructions.
2.4. MALDI-TOF mass spectrometry
Protein masses were determined by Matrix assisted laser desorp-
tion/ionization time-of-ﬂight (MALDI-TOF) mass spectrometry. Spectra
were recorded and analyzed using a Bruker Autoﬂex III Smartbeam
instrument in the linear positive mode controlled by the proprietary
COMPASSTM 1.2 software package. The Nd-YAG-laser power (355 nm)
was manually adjusted for optimal signal appearance. A freeze-dried
salt- and detergent-free sample was dissolved in fewmicroliters of 30%
ACN in 0.1% TFA. 0.5 μl was spotted on a ground steel target plate,mixed
with 0.5 μl matrix solution (10 mg/ml sinapinic acid in 50% ACN, 0.1%
TFA) and left to dry at room temperature. Commercially available
standard protein mixtures were spotted on the same target for
calibration purposes prior to sample analyses.
2.5. 2D-electrophoresis (2-DE) and image analysis
The proteins (60 μg) of B. leucurus venomwere separated by 2-DE.
Prior to running the ﬁrst dimension, the IPG strips were placed in the
rehydration tray and the proteins were dissolved in the De Streak
Rehydrate solution (GE Health Care, Sweden), 0.5% IPG buffer pH 3–
10 (GE Health Care). First dimension IEF was carried out in an Ettan
IPGphor 3 (GE Health Care) as described by the manufacturer.
Immobiline strips 7 cm, pH 3–10 linear (GE Health Care) were
employed for the ﬁrst dimension separation at 20 °C using a four-
phase electrophoresis program: 300 V to reach 200 Vh; 1000 V to
reach 300 Vh; 5000 V to reach 4000 Vh; and 5000 V to reach 1250 Vh
(total accumulated 5800 Vh with 50 μA/strip). Prior to running the
second dimension the proteins in the strip were reduced and
alkylated by sequencial incubation in the following solutions:
75 mM Tris HCl pH 8.8, 6 M urea, 3% glycerol, 2% SDS, 0.002%
bromophenol blue (equilibration buffer-EB), 10 mg/ml DTT for
20 min; and then a solution of 25 mg/ml iodoacetamide in EB for
20 min. Also, SDS-PAGE was done in a mini gel 7.5 cm 12.5%
polyacrylamide gel. Coomasie blue was employed for protein staining.
Direct scanning and image analysis was performed using an Image
Master 2D Platinum 7 (GE Health Care).
2.6. Glycosylation studies
The estimation of the carbohydrate content in Bl-LAAO was
performed by using a glycoprotein carbohydrate estimation kit
(Pierce) according to the manufacturer's instructions. For the
determination of N-linked sugars, the enzyme was submitted to
treatment with PNGase F. 200 μg of native Bl-LAAO was dissolved in
90 μl of denaturing buffer (0.5% SDS, 1% β-mercaptoethanol). The
sample was denatured by boiling for 10 min. After addition of 10 μl of
reaction buffer (0.05 M phosphate, pH 7.5), 10 μl of 10% NP-40 and 5
units of recombinant PNGase F, the sample was incubated at 37 °C for
15 h. Deglycosylation was subsequently detected by size reduction in
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Furthermore, protein-linked glycosylation was measured using
the DIG Glycan Differentiation Kit (Roche Diagnostics, Mannhein,
Germany) according to the manufacturer's instructions.
2.7. Enzymatic assays
To measure LAAO activity, a reaction mixture (1 ml) containing
10 μl horseradish peroxidase (1 mg/ml), 10 μM OPD, and 100 μM L-
leucine in 0.1 M Tris–HCl buffer, pH 8.5 was incubated at 37 °C.
The reaction was started by adding crude venom or puriﬁed Bl-LAAO
(1–2 μg) and monitored at 436 nm over 20 min. Reactions were
stopped by the addition of 100 μl of 60% acetic acid. One unit of the
substrate activity was deﬁned as the oxidation of 1 μMof L-leucine per
min. To test the enzymatic speciﬁcity of BL-LAAO, L-leucine was
replaced with other L-amino acids under identical assay conditions.
The amount of puriﬁed Bl-LAAO in the reaction mixture was 0.66 μM.
Protein concentration was determined using a BCA protein assay kit
(Pierce) with bovine serum albumin as standard.
2.8. Stability assays
To determine the optimum pH of Bl-LAAO, the puriﬁed enzyme
was incubated at 25 °C for 30 min under different pH conditions
(sodium acetate buffer pH 4.5–5.5; Hepes buffer pH 6.5–7.5; Tris–HCl
buffer pH 8.5; borate buffer pH 9.5–10.5) and enzyme activity was
determined using L-Leu as substrate. To investigate the effect of
lyophilization and freezing, aliquots (1 mg) of the native Bl-LAAO in
25 mM Hepes buffer pH 7.5 were stored for one month at 4 °C and
−20 °C. Separate aliquots (3 ml) were dialyzed overnight against
25 mMHepes buffer, pH 7.5, containing 50 mM KCl. After dialysis, the
sample was placed in 50% glycerol and stored at 4 °C. Since the
enzyme is susceptible to inactivation/reactivation, in each assay the
enzyme (frozen-, maintained at 4 °C or lyophilized) was pre-
incubated in acetate buffer, pH 5.0 for 30 min at 37 °C.
2.9. Generation of antibodies speciﬁc for Bl-LAAO
Puriﬁed Bl-LAAO (250 μg/ml in phosphate buffered saline, pH 7.4)
was emulsiﬁed with 1 ml of Freunds complete adjuvant for the ﬁrst
immunization and with Freunds incomplete adjuvant for the booster
immunizations. Aliquots of 0.5 ml of this emulsion were injected
(subcutaneously) into four sites in the back of one rabbit (New
Zealand 2.5 kg). Injections were repeated biweekly and serum was
obtained after the third injection. The IgG fraction was puriﬁed by
afﬁnity chromatography on protein A-Sepharose.
2.10. Immunoblot and enzyme-linked immunoabsorbent assay (ELISA)
For analysis of the immunological reactivity of several different pit
viper venoms against the anti-Bl-LAAO IgG, western immunoblotting
and ELISA were used. The enzyme Bl-LAAO (4 μg) was subjected to
SDS-PAGE (12% gel) under reducing conditions, then eletrophoreti-
cally transferred onto a nitrocellulose membrane according to the
instruction manual (Bio Rad Laboratories). One gel of 2-DE containing
separated proteins from B. leucurus venom was also used for
immunoblot assay under similar experimental conditions. ELISA
plate was coated with 100 μl of 0.5 μg/well of each antigen (Bl-L-
AAO or crude venoms) in 0.05 M carbonate buffer, pH 9.6. After
washing with 0.05% Tween-saline, a blocking solution (2% casein in
phosphate buffered saline-PBS) was added (1 h at room tempera-
ture). After two washes with the same solution, anti-Bl-L-AAO
antibody previously diluted in PBS containing 0.25% casein and
0.05% Tween 20 (0.015 to 2 μg/well) was added and incubated for 1 h
at 37 °C. After six washes, peroxidase-coupled anti-rabbit IgG (Sigma,
diluted 1:12000) was added and incubated for 1 h at roomtemperature. The wells were washed and 100 μl of an OPD solution
(0.33 mg/ml in citrate buffer, pH 5.0, in the presence of 0.012% H2O2)
was added (15 min at room temperature). The reaction was stopped
by adding 20 μl of a 1:20 dilution of sulfuric acid. Absorbance values
were measured at 492 nm.
2.11. Platelet aggregation studies
Venous blood was collected with informed consent from healthy
volunteers who denied taking any medication in the previous two
weeks. Aggregation in citratedplatelet-richplasma(PRP)wasmeasured
in a PACKS-4 platelet aggregation system (Helena Laboratories, USA).
PRP was prepared by centrifugation of citrated blood at 1000 rpm for
10 min. After removal of PRP, the remaining blood was centrifuged at
3000×g for 10 min and platelet poor plasma (PPP) was collected. The
platelets were left for approximately 40 min at room temperature to
recover their sensitivity to aggregating agents. Inhibition of ADP- or
collagen-induced platelet aggregation was monitored by adding Bl-
LAAO (0.1–2.0 μM) for 3 min prior to the addition of agonist (5–10 μM
ADP or 2.5–10 μg/ml collagen). Humanwashed plateletswere prepared
as described [5]. Washed platelets were suspended in Tyrode's solution
and adjusted to about 3×108 platelets per ml. The inhibition of platelet
aggregation was normalized to the maximum aggregation in the
absence of enzyme.
2.12. Cell lines and cell culture
Human gastric carcinoma cell line MKN-45 was obtained from the
Institute of Pathology, University of Porto, (Portugal), cultured and
maintained in RPMI1640medium(Sigma). Thehuman cell linesHUTU
(adeno carcinoma), RKO (colon carcinoma) and ﬁbroblast LL-24 were
from American Type Culture Collection (ATCC, USA) maintained in
EMEM (Sigma) and HAMF12K (Sigma) medium respectively, supple-
mented with 10% (v/v) fetal bovine serum, 4% glutamine, 50 units/ml
penicillin, 50 μg/ml streptomycin, and kept in controlled atmosphere
(5% CO2 incubator at 37 °C).
2.13. Flow cytometry
To investigate whether Bl-LAAO binds to cells, 5×10−5 of HUVEC
(Human Umbilical Vein Endothelial Cells: PromoCell, Heidelberg,
Germany) and the endothelial cell line Eahy926 [21] were incubated
with or without 10 μM/ml of Bl-LAAO for 30 min at 4 °C after the
blocking step using 1% horse serum in PBS. Rhodocetin, an antagonist
of α2β1 integrin [22] isolated from the venom of the Malayan pit
viper (Calloselasma rhodostoma) was used as a positive control in a
concentration of 5 μg/ml under the same conditions. After this
procedure, cells were washed twice with PBS and primary antibodies
against rhodocetin (1:1000) and Bl-LAAO (2 μg/ml), both raised in
rabbit, were added. IgG from rabbit serum (1:1000) (Sigma,
Germany) was used as an isotype control. After 30 min of incubation
at 4 °C, cells were washed again and stained with the secondary Alexa
Fluor 568-conjugated antibody against rabbit (Molecular Probes,
USA) was incubated using also the same conditions. Cells were
analyzed using a CyFlow® device (Partec, Germany) and acquired
data were plotted as histograms using the WinMDI2.9 program.
2.14. Measurement of H2O2 production
EMEM cell culture medium (100 μl/sample) was incubated with
Bl-LAAO at various concentrations (1, 10, 20, 50, 100 μg), 50 μg/ml
peroxidase and 0.1 mg/ml OPD at 37 °C for several intervals. Then, the
quantity of the generated H2O2 was determined by a peroxidase-
coupled assay [12].
Fig. 1. Puriﬁcation of an L-amino acid oxidase from the venom of Bothrops leucurus. First
step: Lyophilized B. leucurus venom (2 g, 1850 mg protein) was loaded onto two
(100×2.5 cm each) columns in series of Sephacryl S-200. The columns were
equilibrated and eluted with 50 mM ammonium acetate buffer (pH 7.4) containing
0.3 M NaCl, at a ﬂow rate of 7 ml/h. Active fraction 2 indicated by a bar was
concentrated for the next step. Second step: Fraction 2 was subsequently applied to a
Sephacryl S-300 (100×1.5 cm) column, which was equilibrated and eluted with
25 mM Tris–HCl buffer (pH 8.0) containing 10 mM NaCl. The active fraction 2-II was
dialyzed against distilled water and lyophilized. Third step: 83 mg protein from
Sephacryl S-300 gel ﬁltration column was applied to a DEAE ion-exchange column
(1.6×20 cm), equilibrated with 50 mM Tris–HCl buffer, pH 8.5 and eluted with 0–0.3 M
NaCl linear gradient in the same buffer at a ﬂow rate of 12 ml/h.
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Cytotoxicity of native Bl-LAAO and B. leucurus crude venom was
tested against LL-24, MKN-45, RKO and HUTU cell lines by MTT assay
and the LIVE/DEAD viability/cytotoxicity Kit for mammalian cells
(Molecular Probes, USA) assay according to the manufacturer's
instruction. The test provides a two-color ﬂuorescence cell viability
assay that is based on the simultaneous determination of live and
dead cells with two probes that measure recognized parameters of
cell viability-intracellular esterase activity and plasma membrane
integrity. In brief, 105 cells/well were plated in a 96-well microtiter
plate. Then cells were exposed to the test samples (Bl-LAAO or crude
venom: 1, 2, 4, 10 and 20 μg/ml) for 12 or 24 h at 37 °C. Furthermore,
MKN-45 and RKO (105 cells) in RPMI 1640 medium (150 μl) were
added to 96-well microtiter plates for 12 h before 50 μl of various
concentrations (MKN 45=1.25, 2.5, 5,10 and 20 μg/ml; RKO=0.1,
0.25, 0.5, 1, 2, and 4 μg/ml) of Bl-LAAO or crude venom were added.
After 24 h of incubation, 50 μl of 50 mg/ml MTT in PBS was added to
each well for 4 h. After removing the medium, 100 μl of DMSO was
added to each well for 10 min at room temperature to solubilize the
MTT-formazan product. After 30 min at room temperature the plate
was read with a microplate reader at 503 nm. All the measurements
were performed in triplicate. The EC50 value was calculated and
compared with the control cell culture.
2.16. Characterization of Bl-LAAO action on promastigotes
Promastigotes of Leishmania chagasi (MHOM/BR/74/PP75) and
L. braziliensis (MHOM/BR/75/M2903), 4×105/well were incubated
with crude venom or Bl-LAAO (0.5, 1, 2, 4, and 8 μg/ml) in absence or
presence of catalase (100 μg/ml) for 18 h at 25 °C in a microplate
assay. Control groups without Bl-LAAO, with or without catalase, and
with or without H2O2 (5 mM) were also tested. Parasites were
incubated in Schneider Insect Medium' (Sigma) supplemented with
10% fetal bovine serum (Invitrogen), and penicillin 100 units/ml,
streptomycin 50 μg/ml. The viability was determined by staining with
Trypan Blue (1:1) and counting viable cells using a Neubauer counter
camera. Values of EC50 were determined from a dose–response curve.
2.17. Other assays
Proteolytic activity was measured with dimethylcasein (DMC) as
substrate, and clotting activity on human ﬁbrinogen was tested as
reported previously [14]. Hemorrhagic activity was assessed by
injecting (subcutaneosly) doses of 10, 20 and 50 μg/mouse (18–
22 g) as described [23]. To evaluate if the native enzyme is a lethal
component different concentrations of Bl-LAAO (10, 30, 50 and
100 μg), were injected (i.p.) into mice (male CF strain, groups of 5
animals at each dose).
3. Results
3.1. Isolation of B. leucurus venom LAAO
LAAO was puriﬁed from 2 g (1850 mg protein) of dry venom
according to the procedure described under Materials and methods.
First, the venom was separated in ten fractions (1 to 10) by gel
ﬁltration on Sephacryl S-200 column [17] of which L-amino acid
oxidase activity eluted in fraction 2 (Fig. 1, 1st step). For the second
step of puriﬁcation, the proteins of fraction 2 with Mr of approxi-
mately 60 kDa were concentrated with a Microcon centrifugal ﬁlter
unit (Millipore Corp.), the active material (275 mg) was applied to a
Sephacryl S-300 column (Fig. 1, 2nd step). The major fraction 2-II
(tubes 22–24) which possessed oxidase activity was collected,
desalted and lyophilized. Analysis of fraction 2-II by SDS-PAGE (12%
gel) showed minor contaminants. Therefore, this material (83 mg)was further puriﬁed by anion-exchange chromatography on a column
of DEAE Sepharose CL 6B, at pH 8.5, using a gradient of NaCl as eluent.
Chromatography of fraction 2-II on DEAE column resulted in one peak
with high LAAO activity (Fig. 1, 3rd step). An aliquot of this fraction
gave one peak in RP-HPLC on a C4 column (not shown), and a unique
sequence of amino acids at the N-terminal (Fig. 2a) a single peak in
Fig. 2. (a) Alignment of N-terminal sequence of Bl-LAAO with those of other venom
LAAOs. Different or similar residues are in bold. The GenBank accession numbers of the
N-terminal sequences of LAAOs used in the alignment analysis are presented in
parenthesis. (b) MALDI-TOF mass spectrum of native Bl-LAAO from B. leucurus venom.
Fig. 3. Molecular mass determination of Bl-LAAO. (a) Size-exclusion gel ﬁltration
chromatography of Bl-LAAO on Sephacryl S-200 shows that Bl-LAAO elutes as a single
peak. An equation (y=−0.0428x+5.3273) was deduced according to values of log Mr
and elution volume of protein standards. The inset shows elution volumes of protein
standards: BSA, 66 kDa; ovalbumin, 45 kDa; trypsinogen, 25 kDa, and α-lactalbumin,
and 14.4 kDa, demonstrating that native (non-denatured) Bl-LAAO has Mr of ~56 kDa.
(b) SDS-PAGE (12% gel) of Bl-LAAO under non reducing (NR) and reduced (R)
conditions. (c) SDS-PAGE (12% gel) of undigested (1), and of Bl-LAAO after treatment
with PNGase F (2) or with o-glycosidase (3). Molecular mass markers are shown on the
lane of left.
687G.B. Naumann et al. / Biochimica et Biophysica Acta 1810 (2011) 683–694MALDI Tof MS (Fig. 2b), and only one band in SDS-PAGE under
reducing and non-reducing conditions (Fig. 3b). We named the
puriﬁed protein Bl-LAAO. The ﬁnal step resulted in an overall yield of
21.4% and Bl-LAAO represented 3.7% (w/w) of the total venom
proteins. Table 1 summarizes the puriﬁcation procedure of Bl-LAAO.Table 1
Puriﬁcation of an Bl-LAAO from Bothrops leucurus venom.
Step Protein Enzymatic activity
(mg) (%) Sp. activity
(U/mg)1
Total Yield PF2
(U) (%)
Crude venom 1850 100 5.75 10,637 100 1
Sephacryl S-200 275 14.9 7.9 2172 20.4 1.4
Sephacryl S-300 83 4.5 32 2656 25 5.6
DEAE Sepharose CL-6B 69 3.7 33 2277 21.4 5.7
1 One unit of enzymatic activity was deﬁned as the oxidation of 1 μM L-leucine per
minute. Speciﬁc activity was expressed as U/mg.
2 PF, puriﬁcation factor.3.2. Physico chemical and immunological properties
The apparent Mr of native (non-denatured) Bl-LAAO was approx-
imately 56 kDa determined by size-exclusion chromatography
(Fig. 3a), which suggest that Bl-LAAO is a monomer protein.
Furthermore, the mass of 57,000 Da was detected by MALDI TOF
mass spectroscopy (Fig. 2b), and the puriﬁed proteinase appeared as
an estimated Mr of 60 kDa in SDS-PAGE under reducing conditions
(Fig. 3b). Bl-LAAO is a glycoprotein as analyzed by SDS-PAGE in which
the enzyme showed an approximately 4 kDa lower value Mr after
treatment with PNGase F (Fig. 3c, lane 2). However, incubation with
o-glycosidase did not affect the mobility of the protein in SDS-PAGE
(Fig. 3c, lane 3) indicating the absence of high mannose structure and
little or no o-glycosylation. Furthermore, after blotting onto a
nitrocellulose membrane we tested the Bl-LAAO for its glycoconju-
gates using a panel of lectins with different capacities to recognize
sugar residues typical for N- and o-glycoconjugates (Fig. 4). In
comparison with the respective positive controls (fetuin, carboxy-
peptidase Y, transferrin, asialofetuin), the puriﬁed enzyme (lane E)
gave a positive reaction only with the lectin DSA (Fig. 4, lane E, upper
panel), which recognizes the sugar motif galactose-β (1–4)-N-
acetylglucosamine. The disaccharide moiety is found in complex and
hybrid N-glycan structures. Interestingly, no sialic acids or othercommon sugar motif typical of o-linked or complex type N-linked
glycoconjugates could be detected within Bl-LAAO indicating the
absence of common o-linked sugar residues within Bl-LAAO.
Although the enzyme appears pure by some physical criteria, it
showed some heterogeneity in mass spectroscopy (not shown) and in
2-DE, the latter one of which separated it into three major
components with pI of 5.8 to 6.1 (Fig. 5a). All three dots were
immunologically recognized by the antiserum against Bl-LAAO
(Fig. 5b). The same Mr-band (at approximately 60 kDa) was also
immunologically detected in the crude venom (Fig. 5c), ruling out a
Fig. 4. Glycoprotein detection on the Bl-LAAO. The puriﬁed enzyme (denoted E), with N-
and o-glycosylated control proteins (denoted +) were transferred to a nitrocellulose
membrane after SDS-PAGE and stained with digoxigenin-labeled lectins and enzyme-
conjugatedanti-digoxigenin-antibodies. The following lectinswereused (target structures
given inparenthesis):Galanthus vivalis agglutinin (GNA) (mannose inhighmannose- type
N-glycoconjugates), Sambuca nigra agglutinin (SNA) ((2–6)-linked sialic acid in complex
type N-glycoconjugates), Datura stramonium agglutinin (DSA) (galactose-β(1–4)-N-
acetylglucosamine as core unit of N-glycoconjugates), Maackia amurensis agglutinin
(MAA) (α(2–6)-linked sialic acid in complex type N-glycoconjugates and o-glycans),
peanut agglutinin (PNA) (galactose-β(1–3)-N-acetylgalactosamine of o-Glycans. Bl-LAAO
is recognized by DSA conﬁrming the presence of N-glycosylation.
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venom. When the anti- Bl-LAAO IgG was tested against the puriﬁed
enzyme and with other pit viper venoms by ELISA, the antibody
reacted with similar afﬁnities with B. leucurus, B. atrox, and B. barnetti.
Low reactivity was observed with L.m.muta (bushmaster) but there
was no reaction with Crotalus durissus terriﬁcus (white venom, as
negative control) (Fig. 5d), which is characterized by its neurotoxic
activity.
Bl-LAAO converts an appropriate substrate in the presence of
oxygen to the correspondingα-keto-carbonic acid releasing H2O2 and
NH3. H2O2 can be detected by horseradish peroxidase-catalyzedconversion of OPD. The photometric OPD signal is linear in a range of
up to 100 μM (data not shown). Therefore, the OPD signal can be
directly recalculated to H2O2 release as a measure for Bl-LAAO activity
(Fig. 6a). The substrate speciﬁcity of the enzymatic activity of Bl-LAAO
was characterized by using various amino acid substrates (Fig. 6b).
The enzyme showed high catalytic activity against the hydrophobic
residues L-Met, L-Leu, L-Norleu, L-Trp, L-Phe and was moderately
active against L-Tyr. The other amino acids were not affected by the
enzyme (Fig. 6b). The optimal pH for enzymatic activity using L-Leu as
substrate was found to be between 7.5 and 8.5 (not shown). Bl-LAAO
in the presence of L-Leu produced H2O2 in a dose- and time dependent
manner (Fig. 6c), and with 50 μg enzyme approximately 60 μM H2O2
was generated in 4 h.
3.3. Cytotoxicity and apoptosis-inducing activity of Bl-LAAO
A number of LAAOs from snake venoms show cytotoxic and
antipathogenic activities, and the H2O2 produced through the
enzymatic reaction appears to be involved in these reactions [9,10,24].
The cytotoxic effect of Bl-LAAO on MKN-45 and RKO cell lines was
examined after 24 h incubation in a dose-dependent manner, we
were able to determine the EC50 values using the MTT method. As
shown in Fig. 7a and b, the EC50 of 0.41 and 0.04 μM, were determined
for MKN-45 and RKO cells, respectively. Under similar experimental
conditions EC50 values of 0.38 and 0.15 μM, were obtained on human
ﬁbroblasts LL-24 cells (control) and on HUTU tumor cells (data not
shown). Catalase (100 μg), an active scavenger of H2O2, inhibited
approximately 25% of the cytotoxicity of Bl-LAAO on MKN-45 cells
(Fig. 7c, lane 4). Indeed, H2O2 (5 mM) exhibits a cytotoxic effect
higher than that of Bl-LAAO and when H2O2 was added simulta-
neously with Bl-LAAO to the cells, the death rate was approximately
95% (Fig. 7c, lane 6). To test whether H2O2, one of the products of the
enzyme reaction, is the main mediator of Bl-LAAO-inducing cytotox-
icity and apoptosis, we quantiﬁed Bl-LAAO-generated H2O2 in HAM
F12medium.When themediumwas incubatedwith Bl-LAAO at 50 μg,
approximately 60 μM H2O2 was produced within 4 h (Fig. 6c), which
is enough to induce apoptosis in MKN-45 cells (not shown). The
toxicity of Bl-LAAO and its reaction products were also tested toxicity
in the Live/Dead viability/cytotoxicity assay in which the polyanionic
dye calcein with intense green ﬂuorescence (ex/em ~495/~515 nm) is
retained within live cells and another dye, ethidium homodimer
(EthD-I) enters dead cells through damaged membranes and binds to
nucleic acids with red ﬂuorescence (ex/em ~495/~635 nm). Thus,
without Bl-LAAO the cells (LL-24, MKN-45 and HUTU) appear
intensely green ﬂuorescent (alive) (Fig. 8, −Bl-LAAO), while in
presence of 10 μg/ml enzyme lead to a bright red ﬂuorescence of dead
cells (Fig. 8, +Bl-LAAO). These nuclear morphological changes are
typical of apoptosis indicating that HUTU cells appears to be more
sensitive to effect of Bl-LAAO than MKN-45 and LL-24, respectively.
These results suggest that Bl-LAAO by producing H2O2 induced
apoptosis and caused cell death.
3.4. Bl-LAAO does not interact with endothelial cells, but affects platelet
function
After injection, snake venom components are quickly disseminated
through the blood stream. To test whether Bl-LAAO is sequestered by
the endothelial lining of blood vessels, we tested its interaction with
both HUVECs (Fig. 9a) and the endothelial cell line EAhy926 (Fig. 9b).
Whereas rhodocetin, an α2β1 integrin speciﬁc inhibitor of Malayan Pit
viper venom, bound to endothelial cells in ﬂow cytometry (Fig. 9a and
b, blue line), Bl-LAAO did not interact with these cells (Fig. 9a and b,
red line), ruling out a direct effect of Bl-LAAO with endothelial cells.
Platelets are another potential and immediate target of blood-
borne snake venom components. However, the reported effects of
snake venom LAAOs on platelet function are still controversial. For
Fig. 5. 2-DE SDS-PAGE pattern of venom proteins from B. leucurus. (a) 60 μg of total proteins were isoeletrically focused (pI range 3–10) followed by separation by SDS-PAGE (12.5%
gel) and Coomassie blue staining. Protein spot of ~60 kDa is indicated by arrow. Molecular mass markers are shown at the left of the gel. (b) Immunoblotting of anti-Bl-LAAO IgG
against venom proteins separated by 2-D SDS-PAGE. Arrows indicates the reactivity of the antibody with the 60 kDa Bl-LAAO. (c) Immunoblotting of anti-Bl-LAAO IgG against
puriﬁed Bl-LAAO and crude venom (CV). (d) Reactivity of anti-Bl-LAAO IgG against several pit viper venoms analyzed by ELISA. 96-well microtitration plates were precoated with
0.5 μg/ml of Bl-LAAO, Bothrops species, L.m.muta and C.d. terriﬁcus snake venoms. Anti-Bl-LAAO IgG was added at different dilutions. Binding was visualized by incubation with
peroxidase-coupled anti-rabbit IgG (diluted 1:12000) and subsequent peroxidase-catalyzed conversion of OPD. The absorbance of pre-immune serum (control) was substracted.
These values are the average of two experiments run in triplicate.
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macmahoni [25] induce platelet aggregation. By contrast LAAOs from
Vipera berus berus [26] and from Naja naja oxiana [27] as well as other
venom enzymes inhibit platelet aggregation triggered by several
agonists dose-dependently in the range of 0.1–2.5 μM. Bl-LAAO did
not induce platelet aggregation by itself at a ﬁnal concentration of
2 μM. But the enzyme dose dependently inhibited the platelet
aggregation of human PRP (Fig. 9c) and washed platelets (Fig. 9d)
induced by collagen and ADP with an IC50 value of 0.21 μM (Fig. 9e).
3.5. Characterization of Bl-LAAO action on promastigotes
Reactive oxygen species among them H2O2 are product of Bl-LAAO
catalysis and serve in the defense of invaded pathogens. Incubation of
promastigotes of Leishmania braziliensis and L. chagasi for 24 h with
the puriﬁed Bl-LAAO resulted in dose-dependent mortality of parasite
numbers with the minimal dose that induces 50% decrease of para-
site numbers estimated at 0.07 and 0.08 μM against L. chagasi andL. braziliensis, respectively (Fig. 10a). This effect was suppressed by
adding catalase (Fig. 10b, lane 2). In addition, promastigotes of
L. chagasi showed H2O2 susceptibility, as observedwhen the H2O2 was
added to the incubation medium (Fig. 10b, lane 3). Under the
same experimental conditions, similar results were obtained against
L. braziliensis (not shown).
In vitro, Bl-LAAO at 0.4 μM and above signiﬁcantly delayed the
progress of the coagulation of ﬁbrinogen by thrombin. However, the
effects ofBl-LAAOonhumanblood coagulation remain largelyunknown
and is a topic of future investigation. Unlike other snake-venom LAAOs,
Bl-LAAO did not produce local hemorrhage in mice at 50 μg/mouse and
was not lethal in mice with doses up to 100 μg/mouse (i.p.).
4. Discussion
This study reports the isolation and characterization of Bl-LAAO, an
LAAO from the venom of B. leucurus. Bl-LAAO is a monomeric and
glycosylated ﬂavoprotein similar to other reported ophidian LAAOs
Fig. 6. LAAO activity of Bl-LAAO. (a) Time dependent oxidase activity of Bl-LAAO. The
oxidase activity was measured in the presence (●) and absence (▲) of L-Leu as
substrate. Data represent mean±S.D. (n=4). (b) L-amino acid species-speciﬁc
LAAO activity of Bl-LAAO. (c) Time and concentration-dependent production of H2O2
by Bl-LAAO. Generation of H2O2 by incubation of Bl-LAAO in HAM F12 medium. Native
enzyme (1–100 μg/ml) was incubated with HAM F12 medium containing peroxidase
and OPD for the intervals indicated as described in Materials and methods. Data shown
represent the average of two independent experiments, with error bars indicating the
maximum and minimum deviation from the average.
Fig. 7. Bl-LAAO induced MKN-45 and RKO carcinoma cells death in a concentration-
dependent manner. (a) MKN-45 cells were incubated with the indicated concentrations
of Bl-LAAO or crude venom for 24 h, (b) RKO cells were treated with different
concentrations of Bl-LAAO under the same conditions. Cell viability is expressed as the
percent of ratio of A503 nm of oxidized formazan MTT of Bl-LAAO-treated cells with the
one of control cells. Values are given as means±S.D. of three independent experiments.
(c) Characterization of Bl-LAAO cytotoxic activity on MKN-45 tumor cells. Cells were
incubated with Bl-LAAO (10 μg/ml) with or without catalase (100 μg) and H2O2
(5 mM). 1, control cells; 2, cells+Bl-LAAO; 3, cells+catalase; 4, cells+Bl-LAAO+
catalase; 5, cells+H2O2; 6, cells+Bl-LAAO+H2O2. The cells were cultured for 24 h.
Bars represent mean±S.D. of three independent experiments.
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consistent with the data obtained by mass spectrometry, 2-DE and gel
ﬁltration chromatography in which the enzyme had aMr of 57, 60 and
56 kDa, respectively. The N-terminal sequence of amino acids shows ahigh homology to other members of this family of toxins, including
the presence of a highly conserved Glu rich motif, which may play a
role in substrate binding. In agreement with the structure of LAAO
from C. rhodostoma [1], this N-terminal region (5–25 residues)
constitutes one part of the substrate-binding domain. Our ﬁnding of
2-DE that the enzyme has a range of isoelectric points (pI) from about
5.8 to 6.1, reﬂects the presence of isoforms with distinct pIs similarly
to other snake venom LAAOs [4,25,28,31]. However, the existence and
the nature of the possible isoforms have to be further investigated.
Fig. 8. Analysis of Bl-LAAO-induced apoptosis. Human ﬁbroblast LL-24, gastric carcinomaMKN-45 and duodenal carcinoma HUTU cell lines were treated with Bl-LAAO (10 μg/ml) for
24 h, and cell cytotoxicity was examined by the LIVE/DEAD Viability/Cytotoxicity assay as described in Materials and methods. As shown, the polyanionic dye calcein is retained
within live cells as intense uniform green ﬂuorescence (controls, panels on the left). EthD-I enters cells through damaged membranes thereby highlighting apoptotic cells by red
ﬂuorescence (panels on right).
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different glycosylation as revealed for other homologous ﬂavoen-
zymes [4,6,28], or they may have been synthesized from different
genes as was suggested for two distinct LAAOs from Pseudechis
australis [30]. Moreover, heterogeneous glycosylation of Bl-LAAO may
also cause this divergence and would not be surprising as the venom
used for puriﬁcation of Bl-LAAO was collected from only two snake
individuals. Lectins which recognize common structural motifs of high
mannose-type and o-glycoconjugates or sialic acid residues failed to
bind to Bl-LAAO. Only the DSA-lectin with a speciﬁcity of recognizing
the N-glycoconjugate core structure bound Bl-LAAO. In line with this,
PNGase F cleaved off a 3.7 kDa large N-glycoconjugate, which
however lacks any commonly linked sialic acid residues. In compar-
ison, LAAO from C. rhodostoma is a dimeric ﬂavoprotein of 55 kDa per
protomer and contains up to 3.7 kDa of glycosylation per protomer
[1,31]. Yet, the crystallized structure of LAAO (C. rhodostoma) exhibits
two N-glycosylation sites at Asn172 and Asn361, both of which seem
very similar in the composition and branching of the sugar chains [31].
An examination of the cross-reactivity between pit viper venoms
from three different genera showed that antibodies against Bl-LAAOcross-reacted with of the venoms of B. leucurus, B. atrox, B, barnetti,
and L.m.muta (bushmaster) to varying degrees. No cross-reactivity
was observed with the white venom from C.d. terriﬁcus (South
American rattlesnake). Characterization of the proteomes of these
snake venoms has identiﬁed LAAOs of 55 kDa (B. atrox), 60 kDa
(B. barnetti) and 60 kDa (L.m.muta, per monomer) (manuscript in
preparation). All of them are yellow venoms and since the puriﬁed
homogeneous Bl-LAAO was bright yellow, its ﬂavin (mainly FAD)
cofactor is likely to cause the venom color [32]. The immunoblotting
of electrophoretically separated proteins of B. leucurus with puriﬁed
IgG anti-Bl-LAAO showed that only one protein species of the crude
venom is recognized. Hence, Bl-LAAO is not degraded in the venom
despite the abundance of distinct proteinases.
Usually the oxidizing activity of snake venom LAAOs is determined
with L-Leu as substrate. In the case of pit viper and viper venoms
hydrophobic amino acids are the best substrates [26,33]. Bl-LAAO
oxidizes a variety of hydrophobic amino acids having the highest
speciﬁcity for Met and Leu when each amino acid is used as substrate.
Few exceptions have been reported for these enzymes, e.g.
the enzyme from Bungarus fasciatus [29] is very active against L-Tyr,
Fig. 9. Bl-LAAO does not directly interact with endothelial cells, but affects human platelet aggregation in PRP andwashed platelets. (a) and (b) Flow cytometric histograms of HUVEC
(a) and EAhy926 cells (b) after treatment with rhodocetin (blue line) and subsequent staining with the respective antibodies, both raised in rabbit. Histogram for the isotype control
rabbit antibodies is shown in grey. (c) Aggregometer tracings of collagen-induced PRP aggregation inhibited by Bl-LAAO (1 and 2 μM) in comparison with the control group (PRP+
collagen 10 μg/ml). PBS was also used as a negative control. (d) Washed platelets suspension were pre-incubated with the indicated concentrations of Bl-LAAO (1; collagen control,
2.5 μg/ml; Bl-LAAO: 2, 0.25 μg/ml; 3, 1 μg/ml; 4, 4 μg/ml; 5, 16 μg/ml). The time points markedwith A, B and C showwhen L-Leu (2 mM), Bl-LAAO and collagen were added to platelet
suspension. (e) Concentration dependence of Bl-LAAO inhibition of ADP-induced platelet aggregation. The data represent the means±S.D. (n=5).
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venom of the elapid king cobra Ophiophagaus hannah, L-Lys is the best
substrate [34]. However, this residue is not oxidized by Bl-LAAO or is
oxidized very slowly or not at all by the majority of venom LAAOs. It
has been reported that LAAOs from different snakes differ in theirsubstrate binding sites [35]. The difference in speciﬁcity of the king
cobra enzyme has been attributed to differences in its primary
structure, since the enzyme has less than 50% identity with the
primary sequences of other homologous enzymes [34]. Furthermore,
the crystallized structure of C. rhodostoma LAAO with L-Phe as
Fig. 10. Characterization of parasiticide effect of Bl-LAAO against promastigotes of
Leishmania sp. (a) Leishmanicide dose-dependent activity induced by Bl-LAAO against
L. braziliensis and L. chagasi. (b) C (control), promastigotes 4×105 cells of L. chagasi in
Schneider Insect medium; 1, promastigotes+10 μg of Bl-LAAO; 2, promastigotes+
10 μg Bl-LAAO+catalase (100 μg); and 3, promastigotes+H2O2 (5 mM). Bars repre-
sent S.D. (n=4).
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nism, leading to the conclusion that hydrophobic residues ﬁt perfectly
into the hydrophobic pocket in the catalytic cavity [36].
It is clear that venom LAAOs affect the function of platelets
(activation or inhibition) through the formation of H2O2 because
catalase, an H2O2 scavenger, inhibits these effects. However, any effect
of ROS on platelets should be observed under conditions of potential
physiological relevance [4]. We have conducted our studies using
either the PRP system or washed platelets. In this work we showed
that Bl-LAAO inhibits collagen-induced platelet aggregation of both
human PRP and washed platelets, which may imply that different
LAAOs affect platelets differently by a mechanism other than via H2O2
production. It would be reasonable to assume that Bl-LAAO has some
inﬂuence on the hemostatic system since the venom of B. leucurus
causes diverse hematological effects, among them a drastic hemo-
static failure. Similar to Bl-LAAO, the enzymes from N. naja kaoutia [4],
V. berus berus [26], V. lebetina [33], N. naja oxiana [27], and Agkistrodon
halys blomhofﬁi [38] inhibited ADP- and collagen platelet aggregation
in dose-dependent fashion (inhibitory concentrations in the range
of 0.1–2.5 μM). Other enzymes such as LAAO from N. atra [5],
B. alternatus [6], and E. macmahoni [25] induced aggregation in the
same concentration range. The potential reasons for these differences
have been discussed by some investigators [4,5,26]. The inhibitory
potency may be connected to the interference of H2O2 in the
interaction between the activated platelet integrin αIIb/β3 and
ﬁbrinogen in the PRP system [3] as well as by the reduced bindingfor ADP in platelets exposed to H2O2. Induction of aggregation is also
explained by H2O2 formation and thromboxane A2 synthesis but
independent of ADP [3]. However, several lines of evidence have
revealed that the biological actions of ophidian LAAOs are only partly
dependent on H2O2, suggesting that there are speciﬁc receptors or
targets on the cells [5,39]. Yet, we have not found any direct
interaction of Bl-LAAO with the cell surface of endothelial cells.
Notwithstanding any direct cell interaction, in the present study we
demonstrated that Bl-LAAO showed cytotoxicity towards a variety of
cultured human cells including gastric carcinoma MKN-45, RKO,
duodenal HUTU tumor cells and ﬁbroblasts. The enzyme was able to
induce apoptosis in these cells as examined by the two color
ﬂuorescence cell viability assay. A number of LAAOs from snake
venomswere reported to show cytotoxicity by inducing cell apoptosis
or necrosis [10–12,26,40]. Apoptosis induced by these enzymes is
mainly attributed to the H2O2 generated upon oxidation of Leu/Met or
other appropriate substrates, however, the speciﬁcity varies from one
enzyme to another. It has been reported that the depletion of an
essential amino acid substrate can trigger apoptosis by some
members of the LAAO family using several cell lines. The enzyme
from C. rhodostoma degrades L-amino acids (Tyr, Phe, Val, Leu) very
efﬁciently within 4 h [40]. The apoptosis-inducing-protein (AIP) from
parasite infected ﬁsh, depleted only Lys frommammalian cell cultured
medium [41]. Studies conducted by Murakawa et al. [41] have
demonstrated that AIP induced apoptosis in cells by two different
mechanisms with different time courses; one fast and dependent on
H2O2, the other slow and independent of H2O2. Similar results were
reported in the characterization of the mechanism of apoptosis
induced by the enzyme from C. rhodostoma [11,40]. The apoptosis-
inducing activity of Bl-LAAO is caused by the enzymatic reaction
product H2O2 as Bl-LAAO at 50 μg/ml was able to produce approxi-
mately 60 μM H2O2 within 4 h in HAMF12 medium. This dose is
enough to induce apoptosis in MKN-45 cells.
We showed that Bl-LAAO presents an anti-Leishmania activity in
vitro. Promastigotes of L .braziliensis and L. chagasi exhibited similar
susceptibility to the venom enzyme. Very low EC50 values (0.07 and
0.08 μM) of the puriﬁed enzyme was obtained against the two
Leishmania species. Removal of H2O2 by addition of catalase to the
medium abolished approximately 90% of the leishmanicidal effect,
suggesting a mechanistic role of H2O2. In this regard, catalase and
superoxide dismutase, were reported in amastigotes of Leishmania sp.,
as its antioxidant defense mechanism [37]. Promastigotes were found
to be deﬁcient in catalase and glutathione peroxidase, with 80 to 90%
promptly killed by macrophage H2O2 production during the infection.
Our data are consistent with these ﬁndings, in which promastigotes of
Leishmania sp. showed high susceptibility to Bl-LAAO.
In conclusion, Bl-LAAO, amajor component of B. leucurus venom, is a
cytotoxin acting primarily via the generation of high amounts of H2O2
which kill the cells. The functional mechanism and corresponding
structural basis of snake venom ﬂavoprotein activity need to be
investigated in detail. Obviously, better knowledge of the mechanism
of action of animal toxins allow us to consider the use of LAAOs as
anticancer agents, as tools in biochemical studies to investigate cellular
processes, and potentially give a better understanding of the enven-
omation mechanism.
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